{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:52:09Z","timestamp":1791366729077,"version":"4.3.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis &amp; Hemostasis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bvth.2026.100205","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:38:39Z","timestamp":1787848719000},"page":"100205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond thrombosis: a scoping review of patient-reported outcomes in antiphospholipid syndrome"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2928-3178","authenticated-orcid":false,"given":"Chanakya","family":"Nayudu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6915-8733","authenticated-orcid":false,"given":"Andrew","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bvth.2026.100205_bib1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.bvth.2026.100205_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.bvth.2026.100205_bib3","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.bvth.2026.100205_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2020004942","article-title":"How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome","volume":"137","author":"Cohen","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bvth.2026.100205_bib5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.bvth.2026.100205_bib6","first-page":"2376","article-title":"Catastrophic antiphospholipid antibody syndrome presenting with multiple thromboses and sites of avascular necrosis","volume":"21","author":"Egan","year":"1994","journal-title":"J Rheumatol"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100205_bib7","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.medcli.2024.02.011","article-title":"Catastrophic antiphospholipid syndrome: lessons from the \u201cCAPS Registry.\u201d","volume":"163","author":"Rodriguez-Pinto","year":"2024","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"10.1016\/j.bvth.2026.100205_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/rheumatology\/keab452","article-title":"Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review","volume":"61","author":"Donnellan","year":"2021","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.bvth.2026.100205_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12020222","article-title":"Cognitive impairment in anti-phospholipid syndrome and anti-phospholipid antibody carriers","volume":"12","author":"Hassan","year":"2022","journal-title":"Brain Sci"},{"issue":"10","key":"10.1016\/j.bvth.2026.100205_bib10","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.jtha.2023.06.020","volume":"21","author":"Cohen","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bvth.2026.100205_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinthera.2019.11.016","article-title":"Value lies in the eye of the patients: the why, what, and how of patient-reported outcomes measures","volume":"42","author":"Ciani","year":"2020","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.bvth.2026.100205_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.semarthrit.2011.12.005","article-title":"Disease-specific patient reported outcome tools for systemic lupus erythematosus","volume":"42","author":"Jolly","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.bvth.2026.100205_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/acr.25301","article-title":"Development of the American College of Rheumatology patient-reported outcome quality measures for systemic lupus erythematosus","volume":"76","author":"Katz","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.bvth.2026.100205_bib14","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3899\/jrheum.151177","article-title":"The reporting of patient-reported outcomes in studies of patients with rheumatoid arthritis: a systematic review of 250 articles","volume":"43","author":"Kilic","year":"2016","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.bvth.2026.100205_bib15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrrheum.2015.116","article-title":"Patient-reported outcomes in core domain sets for rheumatic diseases","volume":"11","author":"van Tuyl","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1016\/j.bvth.2026.100205_bib16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ajh.25880","article-title":"Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: report from the sickle cell disease implementation consortium","volume":"95","author":"Knisely","year":"2020","journal-title":"Am J Hematol"},{"issue":"14","key":"10.1016\/j.bvth.2026.100205_bib17","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/bloodadvances.2023009707","article-title":"Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease","volume":"7","author":"Mucalo","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.bvth.2026.100205_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/PROM.S140932","article-title":"Immune thrombocytopenia: improving quality of life and patient outcomes","volume":"9","author":"Trotter","year":"2018","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.bvth.2026.100205_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/20406207231205431","article-title":"Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study","volume":"14","author":"Kuter","year":"2023","journal-title":"Ther Adv Hematol"},{"issue":"1","key":"10.1016\/j.bvth.2026.100205_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2024.2375177","article-title":"Patient-centric care in primary immune thrombocytopenia (ITP): shared decision-making and assessment of health-related quality of life","volume":"29","author":"Maitland","year":"2024","journal-title":"Hematology"},{"issue":"16","key":"10.1016\/j.bvth.2026.100205_bib21","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/jcm10163754","article-title":"Patient-reported outcomes for quality of life in SLE: essential in clinical trials and ready for routine care","volume":"10","author":"Nguyen","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.bvth.2026.100205_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jval.2013.04.001","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"16","author":"Patrick","year":"2013","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.bvth.2026.100205_bib23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/0961203315580871","article-title":"Impairment of quality of life in patients with antiphospholipid syndrome","volume":"24","author":"Zuily","year":"2015","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.bvth.2026.100205_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3899\/jrheum.101054","article-title":"Thrombovascular events affect quality of life in patients with systemic lupus erythematosus","volume":"38","author":"Balitsky","year":"2011","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100205_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0961203314551809","article-title":"Antiphospholipid (Hughes) syndrome: description of population and health-related quality of life (HRQoL) using the SF-36","volume":"24","author":"Georgopoulou","year":"2015","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.bvth.2026.100205_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5114\/reum\/192028","article-title":"Health-related quality of life impairment is equal for antiphospholipid syndrome whether primary or associated with systemic lupus erythematosus","volume":"62","author":"Haladyj","year":"2024","journal-title":"Reumatologia"},{"issue":"6","key":"10.1016\/j.bvth.2026.100205_bib27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/1756-185X.13045","article-title":"Quality of life in patients with antiphospholipid syndrome is related to disease burden and anticoagulant therapy","volume":"20","author":"Hern\u00e1ndez-Molina","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.bvth.2026.100205_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0961203320970651","article-title":"Damage index for antiphospholipid syndrome during long term follow-up: correlation between organ damage accrual and quality of life","volume":"30","author":"Medina","year":"2021","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.bvth.2026.100205_bib29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/09612033241246360","article-title":"Predictors of damage accrual and its impact on health-related quality of life of thrombotic antiphospholipid syndrome: independent validation of the damage index for antiphospholipid syndrome (DIAPS)","volume":"33","author":"Gaspar","year":"2024","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.bvth.2026.100205_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/acr2.11512","article-title":"Predictors and interrelationship of patient-reported outcomes in antiphospholipid syndrome: a cross-sectional study","volume":"5","author":"Weiner","year":"2023","journal-title":"ACR Open Rheumatol"},{"issue":"8","key":"10.1016\/j.bvth.2026.100205_bib31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0961203320928421","article-title":"Fatigue in adults with primary antiphospholipid syndrome: findings from a mixed-methods study","volume":"29","author":"Bearne","year":"2020","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.bvth.2026.100205_bib32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1177\/09612033241265545","article-title":"A qualitative investigation of the experiences of patients living with antiphospholipid antibodies","volume":"33","author":"Cardwell","year":"2024","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.bvth.2026.100205_bib33","doi-asserted-by":"crossref","first-page":"938","DOI":"10.55563\/clinexprheumatol\/2b73dn","article-title":"Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (the AQUEOUS study)","volume":"39","author":"Chighizola","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100205_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/0961203321990079","article-title":"Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist","volume":"30","author":"de Oliveira Vaz","year":"2021","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.bvth.2026.100205_bib35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/0961203315576858","article-title":"Development and initial validation of a damage index (DIAPS) in patients with thrombotic antiphospholipid syndrome (APS)","volume":"24","author":"Amigo","year":"2015","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.bvth.2026.100205_bib36","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/jth.14936","article-title":"Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: a systematic review and meta-analysis","volume":"18","author":"Ortel","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bvth.2026.100205_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials","volume":"81","author":"Khairani","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.bvth.2026.100205_bib38","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1177\/0961203317703493","article-title":"Independent validation of the adjusted GAPSS: role of thrombotic risk assessment in the real-life setting","volume":"26","author":"Fernandez Mosteirin","year":"2017","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.bvth.2026.100205_bib39","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.22881","article-title":"Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus","volume":"57","author":"McElhone","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.bvth.2026.100205_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.bvth.2026.100205_bib41","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/rheumatology\/kead292","article-title":"Damage measured by damage index for antiphospholipid syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry","volume":"63","author":"Balbi","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bvth.2026.100205_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejim.2021.07.004","article-title":"Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS)","volume":"92","author":"Radin","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.bvth.2026.100205_bib43","first-page":"325","article-title":"Silent cerebral infarction during immune TTP remission: prevalence, predictors, and impact on cognition","volume":"142","author":"Chaturvedi","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bvth.2026.100205_bib44","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1212\/WNL.0000000000004832","article-title":"Silent cerebral infarct definitions and full-scale IQ loss in children with sickle cell anemia","volume":"90","author":"Choudhury","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bvth.2026.100205_bib45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1076029616685427","article-title":"Impact of warfarin persistence on health-care utilization and costs among patients with atrial fibrillation managed in anticoagulation clinics in the United States","volume":"24","author":"Deitelzweig","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"10.1016\/j.bvth.2026.100205_bib46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/STROKEAHA.110.592907","article-title":"Cost efficiency of anticoagulation with warfarin to prevent stroke in Medicare beneficiaries with nonvalvular atrial fibrillation","volume":"42","author":"Mercaldi","year":"2011","journal-title":"Stroke"},{"issue":"24","key":"10.1016\/j.bvth.2026.100205_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12247574","article-title":"Living on oral anticoagulants: duke anticoagulation satisfaction scale results","volume":"12","author":"Mameli","year":"2023","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.bvth.2026.100205_bib48","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.ard.2025.07.016","article-title":"Genetic and epigenetic dysregulation of CR1 is associated with catastrophic antiphospholipid syndrome","volume":"84","author":"Ranjan","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.bvth.2026.100205_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ard.2025.10.006","article-title":"Development and validation of a EULAR disease activity score in antiphospholipid syndrome","volume":"85","author":"Tektonidou","year":"2026","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.bvth.2026.100205_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11926-020-00900-z","article-title":"Health-related quality of life in antiphospholipid syndrome: current knowledge and future perspectives","volume":"22","author":"Desnoyers","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"10.1016\/j.bvth.2026.100205_bib51","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/rheumatology\/keaa172","article-title":"The assessment of patients with the antiphospholipid antibody syndrome: where are we now?","volume":"59","author":"Gaspar","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.bvth.2026.100205_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.rdc.2016.01.007","article-title":"The promise of patient-reported outcomes measurement information system-turning theory into reality: a uniform approach to patient-reported outcomes across rheumatic diseases","volume":"42","author":"Witter","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"7","key":"10.1016\/j.bvth.2026.100205_bib53","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3899\/jrheum.161202","article-title":"Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematosus","volume":"44","author":"Kasturi","year":"2017","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.bvth.2026.100205_bib54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3899\/jrheum.170590","article-title":"Feasibility, validity, and reliability of the 10-item patient reported outcomes measurement information system global health short form in outpatients with systemic lupus erythematosus","volume":"45","author":"Kasturi","year":"2018","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.bvth.2026.100205_bib55","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/acr.23797","article-title":"Psychometric evaluation of the National Institutes of Health patient-reported outcomes measurement information system in a multiracial, multiethnic systemic lupus erythematosus cohort","volume":"71","author":"Katz","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"13","key":"10.1016\/j.bvth.2026.100205_bib56","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1177\/09612033211051275","article-title":"Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous","volume":"30","author":"Moazzami","year":"2021","journal-title":"Lupus"}],"container-title":["Blood Vessels, Thrombosis &amp; Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:09:36Z","timestamp":1791364176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2950327226000707"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100205","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond thrombosis: a scoping review of patient-reported outcomes in antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100205"}}